Currently approved treatments for AD includes four drug forms (the AChE inhibitors donepezil, galantamine, and rivastigmine and the antiglutamatergic drug memantine) and are mainly limited to alleviating cognitive, behavioral, and psychological deficits. Here, ACHE is linked to Alzheimer disease.